Good MorningEquity markets were flat on Wednesday as markets digested the previous day's gains. The S&P hovered near an all-time high and may move up to set a new high soon, but there is risk. The rally has become long in the tooth and ready to correct. The S&P 500 is setting new highs but diverging from indicators, suggesting growing weakness within the market. In this scenario, a small 5% 5o 10% correction would be healthy and set the market up to resume the rally by mid-year.
Tech continues to drag on the markets. Rallies in NVIDIA, Advanced Micro Devices, Meta Platforms, and other mega-cap tech were driving the rally but are now struggling with resistance. If these stocks can't sustain their uptrends, the S&P 500 will likely stall at current levels. With mega-caps looking overbought, investors have begun to turn to small and mid-caps where value can be found. Featured: 120 days remain before new defense mineral rules take effect (Ad) 
|
Materials | |
As the market continues its relentless ascent to new heights, propelled by the surging tech sector and hype surrounding AI, the murmurs of potential interest rate cuts by the Federal Reserve continue, and investors find themselves at a juncture where prudence meets opportunity.
Amid this euphor... Read the Full Story |
|
From Our Partners | | Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldrush, and Cortez Hills, deposits that could hold up to 60 million ounces of gold.
One overlooked explorer controls 142 claims bordering Fourmile and sitting less than a mile from Goldrush. New geological modeling aims to reveal what's beneath this largely untested ground, while a planned 5% royalty spin-off could give shareholders a separate stake in the project. | | Read the full report before the next catalyst hits |
|
Communication Services | |
Comcast Corp. (NASDAQ: CMCSA), Charles Schwab Corp. (NYSE: SCHW) and Alphabet Inc. (NASDAQ: GOOGL) are among institutional-quality large-cap stocks that are currently undervalued.
There are a few reasons why institutions continue showing conviction when it comes to stocks priced below where their... Read the Full Story |
|
Finance | |
The world economy has gone online; there is no turning back from this fact. The only question is how you can profit from this transition. Because more players have become dependent on cybersecurity, the World Economic Forum (WEF) is slowly making this an important theme. Today, you can get ahead o... Read the Full Story |
|
From Our Partners | | A new tool called Oracle tracks insider bets hidden in the predictions market, flagging which stocks and options could be affected.
During beta testing, Oracle identified notable short-term moves including USO up 39% in four days, PLTR up 43% in a day, and WEN up 67% in two days, all through a regular brokerage account.
See how Oracle spots these hidden insider bets before they make headlines. | | Get free access to Oracle and see the data now |
|
Technology | |
The price action in Airship AI Holdings (NASDAQ: AISP) spiked 500% in two days, bringing it to the attention of MarketBeat's unusual trading activity sensors. The spike was accompanied by a 500X increase in volume that promises to keep this stock moving higher.
Why will AirshipAI move higher? Be... Read the Full Story |
|
Consumer Discretionary | |
As digital media expands and personal file collections grow, cloud computing stocks have become a major focal point for investors. This industry, vital for global connectivity and collaboration, has experienced steady growth, particularly highlighted during the ongoing digital transformation spurr... Read the Full Story |
|
From Our Partners | | Trader Chris Pulver says a new SEC document dropping the day-trading limit to $2,000 has created the biggest retail opportunity he has seen in over 30 years.
His strategy targets what he calls Flashpoints - moments when market makers must move billions of dollars on the S-P 500 in a narrow window. Research shows one recent signal would have returned 83.7% in 36 minutes and another 62.8% in 51 minutes.
Lance Ippolito flew to Utah for a full breakdown of the method. | | Tap here to see the complete Flashpoint trading breakdown now |
|
Consumer Discretionary | |
Williams-Sonoma’s (NYSE: WSM) stock surge is due to its persistent outperformance and quality business. The company contracted in 2023 along with the housing market, but cash flow remained solid, driving substantial capital returns for investors. The Q4 results continue the trend and point t... Read the Full Story |
|
Finance | |
Investment houses like The Goldman Sachs Group Inc. (NYSE: GS) have an average winning ratio of over 85% in their trading business. You can wonder how they achieve these results, or you can rest assured that their idea-generation process relies heavily on a “top-down” analysis. Today, ... Read the Full Story |
|
Consumer Staples | |
Casey’s General Store (NASDAQ: CASY) peaked ahead of its FQ3 release and is correcting afterward, but don’t think the sell-off will continue for long. The company’s results were tepid and mixed but revealed resiliency in a business model that has delivered value to shareholders f... Read the Full Story |
|
Consumer Staples | |
The stock market has absolutely, 100% priced in a rate cut. The market has been expecting a rate cut for more than a year and is, in fact, pricing in a soft landing and sustained economic growth. The question that needs to be answered is whether the market is mispricing a rate cut, and the answer ... Read the Full Story |
|
Healthcare | |
They may not be household names like Meta Platforms Inc. (NASDAQ: META) or investor favorites like Nvidia Corp. (NASDAQ: NVDA), but several small stocks, such as Ultra Clean Holdings, Inc. (NASDAQ: UCTT), Powell Industries Inc. (NASDAQ: POWL) and AdaptHealth Corp. (NASDAQ: AHCO) are outperforming ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, an intravenous-administered antibiotic against MDR Gram-negative pathogens comprising carbapenem-resistant enterobacterales (CRE), acinetobacter baumannii, and pseudomonas aeruginosa, as well as negative bacterial infections in the hospital setting; and SPR720, a novel oral antibiotic agent for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
